Home » Topics » BioWorld Science

BioWorld Science
RSS

New SSTR5 agonists presented by Heptares Therapeutics

May 5, 2020

Intarcia Therapeutics discloses new amylin analogues

May 5, 2020

Viriom initiates phase II study of long-acting injectable VM-1500A

May 5, 2020

Eli Lilly and Company patents new KRAS G12C inhibitors

May 5, 2020

First COVID-19 patient enrolled in ongoing phase III study of AR-301

May 5, 2020

Phase III trial of Solosec for trichomoniasis meets primary endpoint

May 5, 2020

Successful completion of phase II study of SPI-1005 in bipolar disorder

May 5, 2020

FDA approves IND application for CAN-04

May 5, 2020

Transcriptomic insights into Parkinson's disease

May 5, 2020

Insulin cuts both ways in vasculature

May 5, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
Anle-138b reduces mHTT aggregation, improves pathological phenotypes in Huntington’s models
BioWorld Science
Anle-138b (emrusolmin) is a diphenylpyrazole compound that directly interacts with oligomeric species of disease-related aggregating proteins, reducing aggregate...